Up-regulation of SLAP in FLI-1-transformed erythroblasts interferes with EpoR signaling

Rearrangement of theFLI-1locus and ensuing overexpression of FLI-1 protein is an early event in Friend murine leukemia virus (F-MuLV)-induced erythroleukemia. When overexpressed in primary erythroblasts, FLI-1 converts erythropoietin (Epo)-induced terminal differentiation into a proliferative respon...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 102; no. 13; pp. 4555 - 4562
Main Authors Lebigot, Ingrid, Gardellin, Paola, Lefebvre, Laurent, Beug, Hartmut, Ghysdael, Jacques, Quang, Christine Tran
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 15.12.2003
The Americain Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rearrangement of theFLI-1locus and ensuing overexpression of FLI-1 protein is an early event in Friend murine leukemia virus (F-MuLV)-induced erythroleukemia. When overexpressed in primary erythroblasts, FLI-1 converts erythropoietin (Epo)-induced terminal differentiation into a proliferative response. We found thatSLAP, a gene encoding a recently described negative regulator of T-cell antigen receptor function during thymocyte development, is up-regulated both at the RNA and protein levels in FLI-1-transformed erythroblasts. Src-like adaptor protein (SLAP) was found in a specific complex with erythropoietin receptor (EpoR), a cytokine receptor essential to erythroid differentiation. Constitutive expression of SLAP severely impairs hemoglobinization and late survival during Epo-induced terminal differentiation of erythroblasts. This impairment is associated with the specific inhibition of several critical Epo-dependent signaling events, including signal transducer and activator of transcription 5 (STAT5) activation and up-regulation of the expression of the antiapoptoticBCL-Xgene. Our data support a model by which FLI-1 inhibits normal erythroid differentiation through the deregulation of genes encoding adaptors/effectors that modify the signaling output of cytokine receptors normally required for terminal differentiation. (Blood. 2003; 102:4555-4562)
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2003-06-2077